These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1070 related items for PubMed ID: 14969655

  • 1. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC, Perazella MA.
    Am J Med; 2004 Feb 15; 116(4):263-72. PubMed ID: 14969655
    [Abstract] [Full Text] [Related]

  • 2. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
    Giestas A, Palma I, Ramos MH.
    Acta Med Port; 2010 Feb 15; 23(4):677-88. PubMed ID: 20687997
    [Abstract] [Full Text] [Related]

  • 3. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
    Ibrahim HN, Rosenberg ME, Hostetter TH.
    Semin Nephrol; 1997 Sep 15; 17(5):431-40. PubMed ID: 9316211
    [Abstract] [Full Text] [Related]

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 15; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS, Weinberg AJ, Zappe DH.
    J Renin Angiotensin Aldosterone Syst; 2000 Sep 15; 1(3):217-33. PubMed ID: 11881029
    [No Abstract] [Full Text] [Related]

  • 7. From converting enzyme inhibition to angiotensin II receptor blockade: new insight on angiotensin II receptor subtypes in the kidney.
    Wolf G, Neilson EG.
    Exp Nephrol; 1996 Sep 15; 4 Suppl 1():8-19. PubMed ID: 9001892
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K, Ji H.
    Semin Nephrol; 2000 Sep 15; 20(5):402-16. PubMed ID: 11022892
    [Abstract] [Full Text] [Related]

  • 10. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L.
    Am J Hypertens; 2005 Apr 15; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [Abstract] [Full Text] [Related]

  • 11. Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
    Johnston CI, Fabris B, Jandeleit K.
    Kidney Int Suppl; 1993 Jul 15; 42():S59-63. PubMed ID: 8361131
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone is a major factor in the progression of renal disease.
    Ibrahim HN, Rosenberg ME, Greene EL, Kren S, Hostetter TH.
    Kidney Int Suppl; 1997 Dec 15; 63():S115-9. PubMed ID: 9407437
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM.
    Acta Diabetol; 2005 Apr 15; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [Abstract] [Full Text] [Related]

  • 14. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
    Ahmed AK, Kamath NS, El Kossi M, El Nahas AM.
    Nephrol Dial Transplant; 2010 Dec 15; 25(12):3977-82. PubMed ID: 19820248
    [Abstract] [Full Text] [Related]

  • 15. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S, Unger T.
    Drugs; 2002 Dec 15; 62 Spec No 1():43-52. PubMed ID: 12036388
    [Abstract] [Full Text] [Related]

  • 16. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan 15; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renin-angiotensin-aldosterone system and progression of renal disease.
    Rüster C, Wolf G.
    J Am Soc Nephrol; 2006 Nov 15; 17(11):2985-91. PubMed ID: 17035613
    [Abstract] [Full Text] [Related]

  • 19. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA.
    J Hypertens; 2006 Jun 15; 24(6):983-91. PubMed ID: 16685192
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.